Lancet Hiv最新文献_第4页

Due south: navigating volatile health research landscapes. 正南：导航不稳定的健康研究景观。

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-09-01 DOI: 10.1016/s2352-3018(25)00245-0

Stephan Rabie,Hlombekazi Sybil Majokweni,Lwandile Tokwe,Tafadzwa Mautsa,John Joska

引用次数: 0

Immunology of infants who are HIV-exposed uninfected in the parental combination antiretroviral therapy era. 在父母联合抗逆转录病毒治疗时代暴露于hiv的未感染婴儿的免疫学。

IF 13 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/S2352-3018(25)00184-5

Melanie A Gasper, Anna-Ursula Happel, Sonwabile Dzanibe, Jennifer Slyker, Heather B Jaspan

{"title":"Immunology of infants who are HIV-exposed uninfected in the parental combination antiretroviral therapy era.","authors":"Melanie A Gasper, Anna-Ursula Happel, Sonwabile Dzanibe, Jennifer Slyker, Heather B Jaspan","doi":"10.1016/S2352-3018(25)00184-5","DOIUrl":"https://doi.org/10.1016/S2352-3018(25)00184-5","url":null,"abstract":"<p><p>The introduction and programmatic scale-up of universal antiretroviral therapy in pregnancy (option B and option B+) and the subsequent universal test-and-treat approaches have dramatically reduced infant HIV-1 acquisitions globally, with a parallel increase in the number of infants who are HIV-exposed uninfected (HEU). Although infants who are HEU have historically had higher risk of morbidity and mortality than infants who are HIV unexposed, effective parental viral suppression has enabled people living with HIV to carry healthier pregnancies and realise the benefits of optimised feeding practices that support the transfer of key nutrients and immune factors through their parent's own milk. However, residual, heightened inflammation, altered gut microbiome, and differences in innate and adaptive immunology in infants who are HEU remain, and might contribute to persistent, heightened infectious morbidity. Parental HIV infection continues to influence child health in the option B and option B+ era; future research is needed to uncover underlying mechanisms and long-term implications of these strategies.</p>","PeriodicalId":48725,"journal":{"name":"Lancet Hiv","volume":" ","pages":""},"PeriodicalIF":13.0,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144975015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial 比替格拉韦、恩曲他滨和替诺福韦阿拉那胺与利托那韦增强的基于蛋白酶抑制剂的抗逆转录病毒治疗和海地二线治疗的病毒抑制：一项开放标签、随机、非劣效性试验

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/s2352-3018(25)00130-4

Patrice Severe MD, Samuel Pierre MD, Fabienne Homeus MD, Jean Bernard Marc MD, Letizia Trevisi PhD, Maria Linda Aristhomene BS, Guirlaine R Bernadin BS, Kerlyne Lavoile BS, Vanessa Rivera BS, Carl Frederic Duchatellier MD, Marie Josee Joseph BS, John Wu MBA, Vanessa Rouzier MD, Fabiola Preval BS, Evens Jean BS, Jodany Bernadin BS, Abigail Zion BS, Guyrlaine Pierre Louis Forestal PharmD, Santiago Avila-Rios PhD, Claudia Garcia Morales PhD, Adina Zhang MS, Dennis Israelski MD, Alexandra Apollon BS, Emelyne Dumont BS, Elizabeth Fox PhD, Pierre-Yves Cremieux PhD, Prof Jean W Pape MD, Sean E Collins MD, Bernard Liautaud MD, Prof Paul E Sax MD, Serena P Koenig MD

引用次数: 0

Optimised second-line regimens in the public health approach 优化二线公共卫生方案

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/s2352-3018(25)00186-9

Nicholas I Paton

引用次数: 0

Highlights of the 13th IAS Conference on HIV Science 第十三届国际艾滋病学会艾滋病科学会议的亮点

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/s2352-3018(25)00243-7

Peter Hayward

引用次数: 0

A moment of reckoning 清算的时刻

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/s2352-3018(25)00244-9

The Lancet HIV

引用次数: 0

Immunology of infants who are HIV-exposed uninfected in the parental combination antiretroviral therapy era. 在父母联合抗逆转录病毒治疗时代暴露于hiv的未感染婴儿的免疫学。

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/s2352-3018(25)00184-5

Melanie A Gasper,Anna-Ursula Happel,Sonwabile Dzanibe,Jennifer Slyker,Heather B Jaspan

{"title":"Immunology of infants who are HIV-exposed uninfected in the parental combination antiretroviral therapy era.","authors":"Melanie A Gasper,Anna-Ursula Happel,Sonwabile Dzanibe,Jennifer Slyker,Heather B Jaspan","doi":"10.1016/s2352-3018(25)00184-5","DOIUrl":"https://doi.org/10.1016/s2352-3018(25)00184-5","url":null,"abstract":"The introduction and programmatic scale-up of universal antiretroviral therapy in pregnancy (option B and option B+) and the subsequent universal test-and-treat approaches have dramatically reduced infant HIV-1 acquisitions globally, with a parallel increase in the number of infants who are HIV-exposed uninfected (HEU). Although infants who are HEU have historically had higher risk of morbidity and mortality than infants who are HIV unexposed, effective parental viral suppression has enabled people living with HIV to carry healthier pregnancies and realise the benefits of optimised feeding practices that support the transfer of key nutrients and immune factors through their parent's own milk. However, residual, heightened inflammation, altered gut microbiome, and differences in innate and adaptive immunology in infants who are HEU remain, and might contribute to persistent, heightened infectious morbidity. Parental HIV infection continues to influence child health in the option B and option B+ era; future research is needed to uncover underlying mechanisms and long-term implications of these strategies.","PeriodicalId":48725,"journal":{"name":"Lancet Hiv","volume":"11 1","pages":""},"PeriodicalIF":16.1,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144959990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correction to Lancet HIV 2025; 12: e638-48. 《柳叶刀HIV 2025》修正；12: e638-48。

IF 13 1区医学

Lancet Hiv Pub Date : 2025-08-27 DOI: 10.1016/S2352-3018(25)00240-1

引用次数: 0

The HIV care crisis in the Philippines 菲律宾的艾滋病毒护理危机

IF 16.1 1区医学

Lancet Hiv Pub Date : 2025-08-21 DOI: 10.1016/s2352-3018(25)00234-6

Amanda Evangelista, Anderson Kirk Nigel G Tan, Adrian E Go

引用次数: 0

Should we be paying more attention to HIV and adult ADHD? 我们应该更加关注艾滋病毒和成人多动症吗？

IF 16.1 1区医学